Bhanji Muna

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-01-31	2025-01-29	Intellia Therapeutics Inc (NTLA)	PS Planned sale	265 -1.3% 9.97 USD 2,642	265 -1.3%	9.97	USD 2,642
2024-06-11	2024-06-10	Veracyte Inc (VCYT)	PS Planned sale	3,870 -14.3% 20.32 USD 78,634	3,870 -14.3%	20.32	USD 78,634
2024-06-10	2024-06-10	Cytokinetics Inc (CYTK)	S Sale	2,000 -10.2% 52.07 USD 104,140	2,000 -10.2%	52.07	USD 104,140
2024-05-30	2024-05-28	Veracyte Inc (VCYT)	PS Planned sale	1,539 -5.4% 21.00 USD 32,319	1,539 -5.4%	21.00	USD 32,319
2023-11-02	2023-10-31	Intellia Therapeutics Inc (NTLA)	PS Planned sale	265 -2.2% 23.90 USD 6,334	265 -2.2%	23.90	USD 6,334
2023-08-02	2023-07-31	Intellia Therapeutics Inc (NTLA)	PS Planned sale	265 -2.1% 42.33 USD 11,217	265 -2.1%	42.33	USD 11,217
2023-07-07	2023-07-07	Cytokinetics Inc (CYTK)	S Sale	2,000 -12.5% 34.12 USD 68,235	2,000 -12.5%	34.12	USD 68,235
2023-07-10	2023-07-06	Intellia Therapeutics Inc (NTLA)	PS Planned sale	1,867 -13.0% 39.30 USD 73,373	1,867 -13.0%	39.30	USD 73,373
2023-06-21	2023-06-16	Veracyte Inc (VCYT)	PS Planned sale	100 -0.3% 27.09 USD 2,709	100 -0.3%	27.09	USD 2,709
2023-06-21	2023-06-16	Veracyte Inc (VCYT)	PS Planned sale	5,793 -16.8% 26.42 USD 153,077	5,793 -16.8%	26.42	USD 153,077
2023-06-01	2023-05-30	Veracyte Inc (VCYT)	PS Planned sale	1,539 -5.9% 25.91 USD 39,875	1,539 -5.9%	25.91	USD 39,875